Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of neuromuscular blockade monitoring vs clinical assessment during cisatracurium paralysis in critically ill patients
2013-000721-31Phase 3Active
- Sponsor
- CHU de Poitiers
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of cisatracurium in respiratory failure (2 arms), sponsored by CHU de Poitiers. Primary endpoint: Cisatracurium dose per 24 hours. Started Sep 2015; status: active.
02
Drugs
cisatracurium
03
Conditions
respiratory failure
Beyond the preview
Go deeper on 2013-000721-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000721-31.